caffeine
Megjelenés
| Clinical data | |||
|---|---|---|---|
| Pronunciation | /kæˈfiːn, ˈkæfiːn/ | ||
| Other names | Guaranine Methyltheobromine 1,3,7-Trimethylxanthine 7-methyltheophylline Theine | ||
| AHFS/Drugs.com | Monograph | ||
| License data | |||
| Pregnancy category |
| ||
| Dependence liability | Physical: Moderate 13% and variable low–high 10–73% Psychological: Low–moderate | ||
| Addiction liability | Relatively low: 9% Sablon:fv | ||
| Routes of administration | Common: By mouth Medical: Intravenous Uncommon: Insufflation, rectal, transdermal, topical | ||
| Drug class | Stimulant; Adenosinergic; Eugeroic; Nootropic; Anxiogenic; Analeptic; PDE inhibitor; Diuretic | ||
| ATC code | |||
| Legal status | |||
| Legal status |
| ||
| Pharmacokinetic data | |||
| Bioavailability | 99% | ||
| Protein binding | 10–36% | ||
| Metabolism | Primary: CYP1A2 Minor: CYP2E1, CYP3A4, CYP2C8, CYP2C9 | ||
| Metabolites | • Paraxanthine 84% • Theobromine 12% • Theophylline 4% | ||
| Onset of action | 45 minutes–1 hour | ||
| Elimination half-life | Adults: 3–7 hours Infants (full term): 8 hours Infants (premature): 100 hours | ||
| Duration of action | 3–4 hours | ||
| Excretion | Urine (100%) | ||
| Identifiers | |||
| |||
| CAS Number | |||
| PubChem CID | |||
| IUPHAR/BPS | |||
| DrugBank | |||
| ChemSpider | |||
| UNII | |||
| KEGG | |||
| ChEBI | |||
| ChEMBL | |||
| NIAID ChemDB | |||
| PDB ligand | |||
| Chemical and physical data | |||
| Formula | C8H10N4O2 | ||
| Molar mass | 194.194 g·mol−1 | ||
| 3D model (JSmol) | |||
| Density | 1.23 g/cm3 | ||
| Melting point | 235 to 238 °C (455 to 460 °F) (anhydrous) | ||
| |||
| |||
Főnév
caffeine (tsz. caffeines)